Target intelligence / Profile preview

Viral lipid envelope (None commonly used)

Target
None commonly used
Molecular classification
Other (lipid bilayer structure)
01

Overview

The viral lipid envelope is a lipid bilayer structure that surrounds the capsid of many viruses, derived from the host cell membrane during viral budding. It contains embedded viral proteins (often glycoproteins known as "spike proteins") critical for virus recognition, attachment, and entry into host cells. The composition typically includes phospholipids, cholesterol, and aminophospholipids (such as phosphatidylserine and phosphatidylethanolamine), the specific proportions varying between viruses[1][2][3]. This envelope may help the virus evade immune detection, mediate fusion with the host cell membrane, and is sensitive to solvents, detergents, and specific antiviral agents. As it is essential for infectivity in many enveloped viruses, the lipid envelope or its components are studied as antiviral drug targets and vaccine components, though targeting must distinguish viral from host membranes to avoid toxicity.

Other names
Viral envelopeLipid envelopeEnvelope membrane
02

Mechanism of action

Destabilization or disruption of the viral lipid envelope, leading to loss of infectivity. Blocking membrane fusion required for virus entry. Targeting externalized phospholipids (PS, PE) to trigger immune clearance or block function.

03

Biological functions

Viral entry/fusion with host cellImmune evasionViral budding and maturationHost cell recognition (via embedded glycoproteins)
04

Disease associations

Infection (Critical for infection by enveloped viruses including HIV, Influenza, Herpesviruses, SARS-CoV-2, etc.)Other (implicated in immune evasion and chronicity of viral diseases)
05

Safety considerations

Host toxicity of broad-spectrum membrane-active agentsPotential for off-target effects, damaging host cell membranes when non-selective agents are usedRapid mutability and adaptation by viruses—envelope composition can change to escape inhibitors
06

Interacting drugs

Enfuvirtide

4 more in the full profile.

07

Biomarkers

Phosphatidylserine (PS) exposureEnvelope glycoproteins (GP120/GP41 in HIV, HA/NA in influenza; usually proteins, but sometimes the envelope itself is assessed as a marker of virus integrity)

Beyond the preview

Go deeper on Viral lipid envelope (None commonly used).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viral lipid envelope (None commonly used).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call